KRYS
Krystal Biotech, Inc.
Stock
$322.28−3.03 (−0.93%)Close Oct 2, 2026
- Research and development, 2025
- $58M
- YoY, 2025
- +8.3%
- 5-year CAGR
- +26.5%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $58M | +8.3% |
| 2024 | $54M | +15.4% |
| 2023 | $46M | +9.4% |
| 2022 | $42M | +52.3% |
| 2021 | $28M | +55.5% |
| 2020 | $18M | +14.9% |
| 2019 | $16M | +101.2% |
| 2018 | $7.8M | +141.9% |
| 2017 | $3.2M | +332.9% |
| 2016 | $741K | — |